Article Per Year (5 Year)
p-Index From 2020 - 2025
0.408
P-Index
This Author published in this journals
All Journal Jurnal Riset Kefarmasian Indonesia
Niko Prasetya
Sekolah Tinggi Ilmu Kesehatan IKIFA
Health Professions Immunology & microbiology Medicine & Pharmacology Nursing Public Health

Published : 2 Documents Claim Missing Document
Claim Missing Document
Check
Articles

Found 2 Documents
Search

 1 
GAMBARAN PENGGUNAAN OBAT PADA PASIEN PENYAKIT GINJAL KRONIK (PGK) YANG MENJALANI HEMODIALISIS DI RS X BEKASI PERIODE JANUARI – MARET 2020 Niko Prasetya; Herty Nur Tanty; Honey Iskandar; Retnayu Pranacistri
Jurnal Riset Kefarmasian Indonesia Vol 4 No 2 (2022): Jurnal Riset Kefarmasian Indonesia
Publisher : APDFI (Asosiasi Pendidikan Diploma Farmasi Indonesia)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33759/jrki.v4i2.269

Abstract

Chronic Kidney Disease (CKD) is a condition of kidney damage that occurs for 3 months or more in the form of structural or functional abnormalities of the kidneys with or without a decrease in the Glomerular Filtration Rate. So far, treatment for CKD can be done by hemodialysis, Continuous Ambulatory Peritoneal Dialysis (CAPD) and kidney transplantation. This study aims to determine the description of the use of drugs in CKD patients undergoing hemodialysis at Hospital X Bekasi from January to March 2020. This study was conducted using a descriptive method. Sampling in January - March 2020 was carried out with the total sampling method, namely all electronic prescription sheets of CKD patients undergoing hemodialysis at Hospital X Bekasi. Data were collected by calculating the amount and percentage based on the active substance and class of drugs used by CKD patients undergoing hemodialysis. Based on the results of observations of electronic prescriptions of drugs used by CKD patients undergoing hemodialysis at Hospital X Bekasi during January - March 2020, it can be concluded that the use of drugs based on the active substance is Calcium carbonate 500 mg capsules as many as 10580 capsules (59.07%), Sodium bicarbonate 500 mg tablets 1725 tablets (9.63%), Gentamicin sulfate 80 mg/2 ml inj 868 ampoules (4.85%), Vitamin C (ascorbic acid) 200 mg/2 ml inj 753 ampoules (4.21% ), Recombinant human erythropoietin 3000 IU 678 injection (3.78%).
GAMBARAN TINGKAT PERSEDIAAN OBAT ANTI HIPERTENSI DI APOTEK IMPHI PERIODE JANUARI – MARET 2020 Aries Meryta; Guruh Subagya; Niko Prasetya; M Arman Maulana
Jurnal Riset Kefarmasian Indonesia Vol 4 No 2 (2022): Jurnal Riset Kefarmasian Indonesia
Publisher : APDFI (Asosiasi Pendidikan Diploma Farmasi Indonesia)

Show Abstract | Download Original | Original Source | Check in Google Scholar | DOI: 10.33759/jrki.v4i2.271

Abstract

Hypertension or high blood pressure is the condition when blood pressure is at the value of 130/80 mmHg or more. This condition can be dangerous, if the patient's treatment is constrained by the quality management of a poor pharmaceutical installation (pharmacy). Efficient drug management is one of the most important factors in the success of overall management so that patients can obtain maximum treatment, and aim to avoid excess (stagnant) and deficiency (stockout) drug availability in pharmacies. The study aims to determine the degree of antihypertensive drug supply at Imphi Pharmacy from January to March 2020. This type of research uses non-experimental methods, which are types of research using quantitative descriptive methods. The sampling method uses a total sampling. The result is that all groups of antihypertensive drugs meet the average supply level of three months with a supply rate of ≥ 1.00 months, and there are two categories of drug stocks are ideal stock (supply levels ≥ 1.00 to ≤ 3.00) and stock is not ideal (inventory levels ≥ 3.00) and the most widely used antihypertensive drugs amlodipine 5 mg with an average use of 3 months as many as 1880 tablets with a stock rate of 1.22 months. All classes of antihypertensive drugs at Imphi Pharmacy each have a slowmoving drug resulting in a high level of drug supply. High levels of drug supply are influenced by several factors such as the number of declining drug requests, excess stock in the warehouse, and the transfer of the drug from generic to patent or otherwise by a physician.
Co-Authors Aries Meryta Guruh Subagya Herty Nur Tanty Honey Iskandar M Arman Maulana Retnayu Pranacistri